We are live on ! Find out more
NIM

Needham Investment Management Portfolio holdings

AUM $1.96B
1-Year Est. Return 101.23%
This Fund
S&P 500
This Quarter Est. Return
+2.35%
1 Year Est. Return
+101.23%
3 Year Est. Return
+267.12%
5 Year Est. Return
+252.76%
10 Year Est. Return
+1,102.05%
AUM
$376M
AUM Growth
-$18.7M
Cap. Flow
-$20.2M
Cap. Flow %
-5.36%
Top 10 Hldgs %
39.52%
Holding
98
New
9
Increased
11
Reduced
39
Closed
5

Top Sells

Rank Stock Value
1
ESRX
Express Scripts Holding Company
ESRX
+$5.49M
2
P
Everpure Inc
P
+$1.35M
3
AKAM icon
Akamai
AKAM
+$1.33M
4
HES
Hess
HES
+$1.25M
5
VSAT icon
Viasat
VSAT
+$1.25M

Sector Composition

Rank Sector Weight
1 Technology 44.85%
2 Healthcare 19.13%
3 Industrials 14.09%
4 Communication Services 8%
5 Consumer Discretionary 2.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FORM icon
1
FormFactor
FORM
$8.11B
$17.8M 4.74%
1,139,650
VSAT icon
2
Viasat
VSAT
$9.79B
$17.7M 4.71%
236,725
-18,000
-7% -$1.25M
TMO icon
3
Thermo Fisher Scientific
TMO
$211B
$16.6M 4.42%
87,500
-5,000
-5% -$958K
ENTG icon
4
Entegris
ENTG
$19.7B
$16.5M 4.4%
543,000
-9,000
-2% -$276K
PDFS icon
5
PDF Solutions
PDFS
$2.13B
$15.3M 4.06%
972,500
+29,600
+3% +$475K
BA icon
6
Boeing
BA
$165B
$15.2M 4.04%
51,500
SMCI icon
7
Super Micro Computer
SMCI
$19.5B
$13.8M 3.66%
6,584,500
+74,000
+1% +$159K
CMCSA icon
8
Comcast
CMCSA
$79.1B
$12.6M 3.35%
315,000
KVHI icon
9
KVH Industries
KVHI
$177M
$11.6M 3.07%
1,116,973
-39,125
-3% -$435K
GILD icon
10
Gilead Sciences
GILD
$161B
$11.5M 3.07%
161,000
-9,500
-6% -$721K
HQL
11
abrdn Life Sciences Investors
HQL
$585M
$10.6M 2.82%
539,725
-10,581
-2% -$212K
ESRX
12
DELISTED
Express Scripts Holding Company
ESRX
$9.63M 2.56%
129,000
-85,900
-40% -$5.49M
MKSI icon
13
MKS Inc
MKSI
$22.2B
$9.55M 2.54%
101,000
-3,000
-3% -$299K
HQH
14
abrdn Healthcare Investors
HQH
$1.23B
$8.88M 2.36%
393,590
+2,500
+0.6% +$58.5K
AKAM icon
15
Akamai
AKAM
$16.8B
$8.52M 2.27%
131,000
-24,000
-15% -$1.33M
AMBR
16
DELISTED
Amber Road Inc
AMBR
$8.18M 2.18%
1,114,950
+56,945
+5% +$425K
NVMI
17
Nova
NVMI
$13.9B
$7.99M 2.13%
308,500
-2,000
-0.6% -$56.4K
COHR icon
18
Coherent
COHR
$55.2B
$7.98M 2.12%
170,000
KMX icon
19
CarMax
KMX
$8.27B
$7.12M 1.89%
111,000
-3,000
-3% -$214K
LH icon
20
Labcorp
LH
$24.3B
$6.71M 1.79%
48,990
ORBK
21
DELISTED
Orbotech Ltd
ORBK
$6.28M 1.67%
125,000
BDX icon
22
Becton Dickinson
BDX
$43.1B
$6.1M 1.62%
29,213
-3,075
-10% -$644K
EFII
23
DELISTED
Electronics for Imaging
EFII
$6.02M 1.6%
204,000
+20,000
+11% +$669K
REIS
24
DELISTED
Reis, Inc.
REIS
$5.51M 1.46%
266,700
-300
-0.1% -$5.79K
UAL icon
25
United Airlines
UAL
$38.4B
$5.39M 1.43%
80,000

Similar funds

Needham Investment Management's Q4 2017 Portfolio in Review

As of Q4 2017, Needham Investment Management held 98 positions worth $376M, down 4.7% from $395M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Needham Investment Management withdrew a net $20.2M in Q4 2017, closing 5 positions and reducing 39 holdings. Its most notable exit was Analogic Corp, an estimated $570K position sold in full.

By sector, the portfolio is most concentrated in Technology at 45% of assets, up from 42% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Needham Investment Management opened a new position in Aquantia Corp. Common Stock worth $1.69M.

  • Needham Investment Management's largest Q4 2017 buy was Aquantia Corp. Common Stock: 149,164 shares worth $1.69M.
  • Needham Investment Management added most to Aspen Aerogels in Q4 2017, an estimated $769K increase.
  • Needham Investment Management's biggest Q4 2017 reduction was Express Scripts Holding Company, cutting an estimated $5.49M.
  • Needham Investment Management fully exited Analogic Corp in Q4 2017, selling an estimated $570K.
  • Needham Investment Management's ten largest holdings make up 40% of its $376M portfolio in Q4 2017.
  • Needham Investment Management opened 9 new positions and closed 5 in Q4 2017.
  • Needham Investment Management's portfolio value fell 4.7% quarter-over-quarter to $376M.

Based on Needham Investment Management's 13F filing for Q4 2017, filed 14 Feb 2018.